ангиотензин-II 在心力衰竭的老鼠中驱动微质血管相互作用的变化
Ferdinand Althammer1,2, Ranjan K Roy1,3, Matthew K Kirchner1,3
1Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, GA, USA.
Communications biology
|November 20, 2024
概括
心力衰竭通过增加大脑中血管相关的微质细胞引发神经炎症. 阻断 ангиотензин II AT1a 受体减少了这种微质的招募,为心血管疾病提供了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
背景情况:
- 中枢神经系统中的微质激活和促炎性细胞因子释放与心力衰竭 (HF) 并发症有关.
- 之前的研究集中在海马体 ангиотензин II (AngII) 信号传递在HF诱导的微质激活中,但潜在的机制和神经血管相互作用仍然不清楚.
- 微质细胞和大脑微血管之间的相互作用,影响血脑屏障的完整性和脑血流,在高血压的背景下还未得到充分研究.
研究的目的:
- 研究心力衰竭对大脑中微质血管界面的影响.
- 探索 ангиотензин II (AngII) 信号传递在HF诱导的微质血管相互作用变化的作用.
- 确定潜在的治疗点,以减轻心血管疾病中的神经炎症.
主要方法:
- 采用了一种成熟的缺血性心力衰竭 (HF) 鼠标模型.
- 定量化血管相关微质细胞 (VAM) 和海马中的AngII AT1a受体表达.
- 将AngII给假老鼠和AT1a受体阻塞剂给HF老鼠,以评估微质反应和TNFα表达.
主要成果:
- 在HF大鼠的海马体中显示出血管相关微质 (VAM) 的丰富性增加.
- 在HF大鼠的大脑中观察到AngII AT1a受体的增加表达.
- 表明AngII的使用诱导了微质对脑毛细血管和TNFα表达的招募,而HF大鼠的AT1aR阻断阻止了这种招募.
结论:
- 心力衰竭导致大脑中微质血管相互作用的增加,其特点是微质细胞向血管招募.
- 通过AT1a受体传递 ангиотензинII (AngII) 信号,在调解HF诱导的微质招募到大脑血管系统方面发挥着至关重要的作用.
- 向微质血管相互作用和AngII信号提供了一个新的治疗策略,用于管理与心血管疾病相关的神经炎症.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
479
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
479
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
590
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
590
01:25Antihypertensive Drugs: Direct Renin Inhibitors
493
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
493